Global VAX : A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023
Published by Elsevier Ltd..
In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) in response to the global COVID-19 pandemic. Using the foundation of decades of U.S. government investments in global health and working in close partnership with local governments and key global and multilateral organizations, Global VAX enabled the rapid acceleration of the global COVID-19 vaccine rollout in selected countries, contributing to increased COVID-19 vaccine coverage in some of the world's most vulnerable communities. Through Global VAX, the U.S. Government has supported 125 countries to scale up COVID-19 vaccine delivery and administration while strengthening primary health care systems to respond to future health crises. The progress made by Global VAX has paved the way for a stronger global recovery and improved global health security.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Vaccine - (2024) vom: 23. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dahl, Benjamin A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 24.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.vaccine.2024.03.054 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370125703 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370125703 | ||
| 003 | DE-627 | ||
| 005 | 20240325235757.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240325s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.vaccine.2024.03.054 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1347.xml |
| 035 | |a (DE-627)NLM370125703 | ||
| 035 | |a (NLM)38523004 | ||
| 035 | |a (PII)S0264-410X(24)00359-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dahl, Benjamin A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Global VAX |b A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Published by Elsevier Ltd. | ||
| 520 | |a In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) in response to the global COVID-19 pandemic. Using the foundation of decades of U.S. government investments in global health and working in close partnership with local governments and key global and multilateral organizations, Global VAX enabled the rapid acceleration of the global COVID-19 vaccine rollout in selected countries, contributing to increased COVID-19 vaccine coverage in some of the world's most vulnerable communities. Through Global VAX, the U.S. Government has supported 125 countries to scale up COVID-19 vaccine delivery and administration while strengthening primary health care systems to respond to future health crises. The progress made by Global VAX has paved the way for a stronger global recovery and improved global health security | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus disease | |
| 650 | 4 | |a Evaluation | |
| 650 | 4 | |a Global Vax | |
| 650 | 4 | |a Implementation | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Vaccine | |
| 650 | 4 | |a Vaccine delivery | |
| 700 | 1 | |a Tritter, Beth |e verfasserin |4 aut | |
| 700 | 1 | |a Butryn, Deena |e verfasserin |4 aut | |
| 700 | 1 | |a Dahlke, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Browning, Sean |e verfasserin |4 aut | |
| 700 | 1 | |a Gelting, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Fleming, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Ortiz, Nancy |e verfasserin |4 aut | |
| 700 | 1 | |a Labrador, Jacqueline |e verfasserin |4 aut | |
| 700 | 1 | |a Novak, Ryan |e verfasserin |4 aut | |
| 700 | 1 | |a Fitter, David |e verfasserin |4 aut | |
| 700 | 1 | |a Bell, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a McGuire, Megan |e verfasserin |4 aut | |
| 700 | 1 | |a Rosenbaum, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Pulwer, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Wun, Jolene |e verfasserin |4 aut | |
| 700 | 1 | |a McCaffrey, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Chowdhury, Maisoon |e verfasserin |4 aut | |
| 700 | 1 | |a Parks, Nida |e verfasserin |4 aut | |
| 700 | 1 | |a Cunningham, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Mounts, Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Curry, Dora |e verfasserin |4 aut | |
| 700 | 1 | |a Richardson, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Grant, Gavin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vaccine |d 1985 |g (2024) vom: 23. März |w (DE-627)NLM012600105 |x 1873-2518 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:23 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.vaccine.2024.03.054 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 23 |c 03 | ||